SEARCH

SEARCH BY CITATION

References

  • Abbas, A.K. & Sharpe, A.H. (1999) T-cell stimulation: an abundance of B7s. Nature Medicine, 5, 13451346.DOI: 10.1038/70905
  • Adler, A.J., Marsh, D.W., Yochum, G.S., Guzzo, J.L., Nigam, A., Nelson, W.G., Pardoll, D.M. (1998) CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. Journal of Experimental Medicine, 187, 15551564.
  • Albert, M.L., Sauter, B., Bhardwaj, N. (1998) Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature, 392, 8689.DOI: 10.1038/32183
  • Altman, J.D., Moss, P.A.H., Goulder, P.J.R., Barouch, D.H., McHeyzer-Williams, M.G., Bell, J.I., McMichael, A.J., Davis, M.M. (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science, 274, 9496.DOI: 10.1126/science.274.5284.94
  • Antin, J.H. (1993) Graft-versus-leukemia: no longer an epiphenomenon. Blood, 82, 22732277.
  • Ardavin, C. (1997) Thymic dendritic cells. Immunology Today, 18, 350361.DOI: 10.1016/s0167-5699(97)01090-6
  • Arpinati, M., Green, C., Heimfeld, S., Heuser, J., Anasetti, C. (2000) Granulocyte-colony stimulating factor mobilizes T-helper 2-inducing dendritic cells. Blood, 95, 24842490.
  • Bakker, A.B., Marland, G., De Boer, A.J., Huijbens, R.J., Danen, E.H., Adema, G.J., Figdor, C.G. (1995) Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro. Cancer Research, 55, 53305334.
  • Banchereau, J. & Steinman, R.M. (1998) Dendritic cells and the control of immunity. Nature, 19, 245252.
  • Bell, D., Chomarat, P., Broyles, D., Netto, G., Harb, G.M., Lebecque, S., Valladeau, J., Davoust, J., Palucka, K.A., Banchereau, J. (1999) In breast cancer tissue, immature dendritic cells reside within the tumour, whereas mature dendritic cells are located in peritumoural areas. Journal of Experimental Medicine, 190, 14171425.
  • Bender, A., Sapp, M., Schuler, G., Steinman, R.M., Bhardwaj, N. (1996) Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. Journal of Immunological Methods, 196, 121135.DOI: 10.1016/0022-1759(96)00079-8
  • Bennett, S.R., Carbone, F.R., Karamalis, F., Miller, J.F., Heath, W.R. (1997) Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. Journal of Experimental Medicine, 186, 6570.
  • Bennett, S.R., Carbone, F.R., Karamalis, F., Flavell, R.A., Miller, J.F., Heath, W.R. (1998) Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature, 393, 478480.DOI: 10.1038/30996
  • Boczkowski, D., Nair, S.K., Nam, J., Lyerly, H., Gilboa, E. (2000) Induction of tumour immunity and cytotoxic T lymphocyte response using dendritic cells transfected with messenger RNA amplified from tumour cells. Cancer Research, 60, 10281034.
  • Boon, T. & van der Bruggen, P. (1996) Human tumor antigens recognized by T lymphocytes. Journal of Experimental Medicine, 183, 725729.
  • Brossart, P., Stuhler, G., Flad, T., Stevanovic, S., Rammensee, H.G., Kanz, L., Brugger, W. (1998) Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes. Cancer Research, 58, 732736.
  • Brossart, P., Heinrich, K.S., Stuhler, G., Behnke, L., Reichardt, V.L., Stevanovic, S., Muhm, A., Rammensee, H.G., Kanz, L., Brugger, W. (1999) Identification of HLA A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies. Blood, 93, 43094317.
  • Buggins, A.G., Lea, N., Gaken, J., Darling, D., Farzaneh, F., Mufti, G.J., Hirst, W.J. (1999) Effect of costimulation and the microenvironment on antigen presentation by leukemic cells. Blood, 94, 34793490.
  • Buhmann, R., Nolte, A., Westhaus, D., Emmerich, B., Hallek, M. (1999) CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells. Blood, 93, 19922002.
  • Burch, P.A., Breen, J.K., Buckner, J.C., Gastineau, D.A., Kaur, J.A., Laus, R.L., Padley, D.J., Peshwa, M.V., Pitot, H.C., Richardson, R.L., Smits, B.J., Sopapan, P., Strang, G., Valone, F.H., Vuk-Pavlovic, S. (2000) Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer. Clinical Cancer Research, 6, 21752182.
  • Carbone, F.R., Kurts, C., Bennett, S.R., Miller, J.F., Heath, W.R. (1998) Cross-presentation: a general mechanism for CTL immunity and tolerance. Immunology Today, 19, 368373.DOI: 10.1016/s0167-5699(98)01301-2
  • Caux, C., Dezutter-Dambuyant, C., Schmitt, D., Banchereau, J. (1992) GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature, 360, 258261.
  • Cella, M., Sallusto, F., Lanzavecchia, A. (1997) Origin, maturation and antigen presenting function of dendritic cells. Current Opinion in Immunology, 9, 1016.
  • Charbonnier, A., Gaugler, B., Sainty, D., Lafage-Pochitaloff, M., Olive, D. (1999) Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias. European Journal of Immunology, 29, 25672578.DOI: 10.1002/(sici)1521-4141(199908)29:08<2567::aid-immu2567>3.0.co;2-s
  • Chen, L. (1998) Immunological ignorance of silent antigens as an explanation of tumor evasion. Immunology Today, 19, 2730.DOI: 10.1016/s0167-5699(97)01180-8
  • Choudhury, A., Gajewski, J.L., Liang, J.C., Popat, U., Claxton, D.F., Kliche, K.O., Andreeff, M., Champlin, R.E. (1997) Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. Blood, 89, 11331142.
  • Choudhury, B.A., Liang, J.C., Thomas, E.K., Flores-Romo, L., Xie, Q.S., Agusala, K., Sutaria, S., Sinha, I., Champlin, R.E., Claxton, D.F. (1999) Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses. Blood, 93, 780786.
  • Cignetti, A., Bryant, E., Allione, B., Vitale, A., Foa, R., Cheever, M.A. (1999) CD34 (+) acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells. Blood, 94, 20482055.
  • Croft, M. (1994) Activation of naïve, memory and effector T cells. Current Opinion in Immunology, 6, 431437.
  • Cull, G., Durrant, L., Stainer, C., Haynes, A., Russell, N. (1999) Generation of anti-idiotype immune responses following vaccination with idiotype-protein pulsed dendritic cells in myeloma. British Journal of Haematology, 107, 648655.
  • Dembic, Z., Schenck, K., Bogen, B. (2000) Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells. Proceedings of the National Academy of Sciences of the United States of America, 97, 26972702.
  • Dhodapkar, M.V., Steinman, R.M., Sapp, M., Desai, H., Fossella, C., Krasovsky, J., Donahoe, S.M., Dunbar, P.R., Cerundolo, V., Nixon, D.F., Bhardwaj, N. (1999) Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. Journal of Clinical Investigation, 104, 173180.
  • Dieu, M.C., Vanbervliet, B., Vicari, A., Bridon, J.M., Oldham, E., Ait-Yahia, S., Briere, F., Zlotnik, A., Lebecque, S., Caux, C. (1998) Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. Journal of Experimental Medicine, 188, 373386.
  • Disis, M.L. & Cheever, M.A. (1996) Oncogenic proteins as tumor antigens. Current Opinion in Immunology, 8, 637642.
  • Disis, M.L., Grabstein, K.H., Sleath, P.R., Cheever, M.A. (1999) Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine. Clinical Cancer Research, 5, 12891297,.
  • Dong, H., Zhu, G., Chen, L. (1999) B7–H1, a third member of the B7 family, co-stimulates T cell proliferation and interleukin-10 secretion. Nature Medicine, 5, 13651369.DOI: 10.1038/70932
  • Dunussi-Joannoppoulos, K., Runyon, K., Erickson, J., Schaub, R.G., Hawley, R.G., Leonard, J.P. (1999) Vaccines with interleukin-12-transduced acute myeloid leukaemia cells elicit very potent therapeutic and long lasting protective immunity. Blood, 94, 42634273.
  • Eggert, A.A., Schreurs, M.W., Boerman, O.C., De Oyen, W.J.B.A.J., Punt, C.J., Figdor, C.G., Adema, G.J. (1999) Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration. Cancer Research, 59, 33403345.
  • Engels, F.H., Koski, G.K., Bedrosian, I., Xu, S., Luger, S., Nowell, P.C., Cohen, P.A., Czerniecki, B.J. (1999) Calcium signaling induces acquisition of dendritic cell characteristics in chronic myelogenous leukemia myeloid progenitor cells. Proceedings of the National Academy of Sciences of the United States of America, 96, 1033210337.
  • Falkenburg, J.H., Smit, W.M., Willemze, R. (1997) Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia. Immunological Reviews, 157, 223230.
  • Falkenburg, J.H., Wafelman, A.R., Joosten, P., Smit, W.M., Van Bergen, C.A., Bongaerts, R., Lurvink, E., Van Der Hoorn, M., Kluck, P., Landegent, J.E., Kluin-Nelemans, H.C., Fibbe, W.E., Willemze, R. (1999) Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes. Blood, 94, 12011208.
  • Fernandez, N.C., Lozier, A., Flament, C., Ricciardi-Castagnoli, P., Bellet, D., Suter, M., Perricaudet, M., Tursz, T., Maraskovsky, E., Zitvogel, L. (1999) Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nature Medicine, 5, 405411.DOI: 10.1038/7403
  • Fields, R.C., Shimizu, K., Mule, J.J. (1998) Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America, 95, 94829487.
  • Gabrilovich, D.I., Chen, H.L., Girgis, K.R., Cunningham, H.T., Meny, G.M., Nadaf, S., Kavanaugh, D., Carbone, D.P. (1996) Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nature Medicine, 2, 10961103.
  • Gabrilovich, D.I., Corak, J., Ciernik, I.F., Kavanaugh, D., Carbone, D.P. (1997) Decreased antigen presentation by dendritic cells in patients with breast cancer. Clinical Cancer Research, 3, 483490.
  • Gabrilovich, D., Ishida, T., Oyama, T., Ran, S., Kravtsov, V., Nadaf, S., Carbone, D.P. (1998) Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood, 92, 41504166.
  • Gallucci, S., Lolkema, M., Matzinger, P. (1999) Natural adjuvants: endogenous activators of dendritic cells. Nature Medicine, 5, 12491255.DOI: 10.1038/15200
  • Galy, A., Travis, M., Cen, D., Chen, B. (1995) Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity, 3, 459473.
  • Gao, L., Bellantuono, I., ElsasSeries, A., Marley, S.B., Gordon, M.Y., Goldman, J.M., Stauss, H.J. (2000) Selective elimination of leukemic CD34 (+) progenitor cells by cytotoxic T lymphocytes specific for WT1. Blood, 95, 21982203.
  • Gong, J., Chen, D., Kashiwaba, M., Kufe, D. (1997) Induction of antitumour activity by immunisation with fusions of dendritic and carcinoma cells. Nature Medicine, 3, 558561.
  • Gong, J., Chen, D., Kashiwaba, M., Li, Y., Chen, L., Takeuchi, H., Qu, H., Rowse, G.J., Gendler, S.J., Kufe, D. (1998) Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells. Proceedings of the National Academy of Sciences of the United States of America, 95, 62796283.
  • Grabbe, S., Beissert, S., Schwarz, T., Granstein, R.D. (1995) Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy? Immunology Today, 16, 117121.
  • Grouard, G., Durand, I., Filgueira, L., Banchereau, J., Liu, Y.J. (1996) Dendritic cells capable of stimulating T cells in germinal centres. Nature, 384, 364367.
  • Grouard, G., Rissoan, M.C., Filgueira, L., Durand, I., Banchereau, J., Liu, Y.J. (1997) The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. Journal of Experimental Medicine, 185, 11011111.
  • Gunn, M., Kyuwa, S., Tam, C., Kakiuchi, T., Matsuzawa, A., Williams, L., Nakano, H. (1999) Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localisation. Journal of Experimental Medicine, 189, 451460.
  • Hart, D.N. (1997) Dendritic cells: unique leukocyte populations which control the primary immune response. Blood, 90, 32453287.
  • Heath, W.R. & Carbone, F.R. (1999) Cytotoxic T lymphocyte activation by cross-priming. Current Opinion in Immunology, 11, 314318.DOI: 10.1016/s0952-7915(99)80050-8
  • Heiser, A., Dahm, P.R., Yancey, D., Maurice, M.A., Boczkowski, D., Nair, S.K., Gilboa, E., Vieweg, J. (2000) Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro. Journal of Immunology, 164, 55085514.
  • Hermans, I.F., Ritchie, D.S., Yang, J., Roberts, J.M., Ronchese, F. (2000) CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity. Journal of Immunology, 2000, 30953101.
  • Houghton, A.N. & Lloyd, K.O. (1998) Stuck in the MUC on the long and winding road. Nature Medicine, 4, 270271.
  • Hsu, F.J., Benike, C., Fagnoni, F., Liles, T.M., Czerwinski, D., Taidi, B., Engleman, E.G., Levy, R. (1996) Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Medicine, 2, 5258.
  • Huang, A.Y., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., Levitsky, H. (1994) Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science, 264, 961965,.
  • Huang, A.Y., Bruce, A.T., Pardoll, D.M., Levitsky, H.I. (1996) Does B7–1 expression confer antigen-presenting cell capacity to tumors in vivo? Journal of Experimental Medicine, 183, 769776.
  • Hung, K., Hayashi, R., Lafond-Walker, C., Lowenstein, C., Pardoll, D., Levitsky, H. (1998) The central role of CD4+ T cells in the anti-tumour immune response. Journal of Experimental Medicine, 188, 23572368.
  • Kawashima, I., Tsai, V., Southwood, S., Takesako, K., Sette, A., Celis, E. (1999) Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells. Cancer Research, 59, 431435.
  • Knight, S.C., Hunt, R., Dore, C., Medawar, P.B. (1985) Influence of dendritic cells on tumor growth. Proceedings of the National Academy of Sciences of the United States of America, 82, 44954497.
  • Kolb, H.J., Schattenberg, A., Goldman, J.M., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonck, L., Niederwieser, D. (1995) Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood, 86, 20412050.
  • Krummel, M. & Allison, J. (1995) CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. Journal of Experimental Medicine, 182, 459465.
  • Kufe, D.W. (2000) Smallpox, polio and now a cancer vaccine? Nature Medicine, 6, 252253.DOI: 10.1038/73082
  • Kugler, A., Stuhler, G., Walden, P., Zoller, G., Zobywalski, A., Brossart, P., Trefzer, U., Ullrich, S., Muller, C.A., Becker, V., Gross, A.J., Hemmerlein, B., Kanz, L., Muller, G.A., Ringert, R.H. (2000) Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids. Nature Medicine, 6, 332336.DOI: 10.1038/73193
  • Kurts, C., Kosaka, H., Carbone, F.R., Miller, J.F., Heath, W.R. (1997) Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8+ T cells. Journal of Experimental Medicine, 186, 239245.
  • Kwak, L.W., Campbell, M.J., Czerwinski, D.K., Hart, S., Miller, R.A., Levy, R. (1992) Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. New England Journal of Medicine, 327, 12091215.
  • Kwak, L.W., Taub, D.D., Duffey, P.L., Bensinger, W.I., Bryant, E.M., Reynolds, C.W., Longo, D.L. (1995) Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor. Lancet, 345, 10161020.
  • Labeur, M.S., Roters, B., Pers, B., Mehling, A., Luger, T.A., Schwarz, T., Grabbe, S. (1999) Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. Journal of Immunology, 162, 168175.
  • Lalvani, A. & Hill, A.V. (1998) Cytotoxic T-lymphocytes against malaria and tuberculosis: from natural immunity to vaccine design. Clinical Science, 95, 531538.
  • Lee, P.P., Yee, C., Savage, P.A., Fong, L., Brockstedt, D., Weber, J.S., Johnson, D., Swetter, S., Thompson, J., Greenberg, P.D., Roederer, M., Davis, M.M. (1999) Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nature Medicine, 5, 677685.DOI: 10.1038/9525
  • Lodge, P.A., Jones, L.A., Bader, R.A., Murphy, G.P., Salgaller, M.L. (2000) Dendritic cell-based immunotherapy of prostate cancer: immune monitoring of a phase II clinical trial. Cancer Research, 60, 829833.
  • Lokhorst, H., Schattemberg, A., Cornelissen, L., Thomas, L., Verdonck, L. (1997) Donor leucocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation. Blood, 90, 42064211.
  • Macatonia, S.E., Hosken, N.A., Litton, M., Vieira, P., Hsieh, C.S., Culpepper, J.A., Wysocka, M., Trinchieri, G., Murphy, K.M., O'Garra, A. (1995) Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. Journal of Immunology, 154, 50715079.
  • Mackensen, A., Herbst, B., Chen, J.L., Kohler, G., Noppen, C., Herr, W., Spagnoli, G.C., Cerundolo, V., Lindemann, A. (2000) Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells. International Journal of Cancer, 86, 385392.DOI: 10.1002/(sici)1097-0215(20000501)86:3<385::aid-ijc13>3.0.co;2-t
  • Maino, V.C. & Picker, L.J. (1998) Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression. Cytometry, 34, 207215.DOI: 10.1002/(sici)1097-0320(19981015)34:5<207::aid-cyto1>3.3.co;2-a
  • Mannering, S.I., McKenzie, J.L., Fearnley, D.B., Hart, D.N. (1997) HLA-DR1-restricted bcr-abl (b3a2)-specific CD4+ T lymphocytes respond to dendritic cells pulsed with b3a2 peptide and antigen-presenting cells exposed to b3a2 containing cell lysates. Blood, 90, 290297.
  • Matsushita, M., Ikeda, H., Kizaki, M., Okamoto, S., Ikeda, Y., Kawakami, Y. (1999) PRAME, a novel tumour marker for the detection of minimal residual disease in leukaemia and lymphoma. Blood, 94, 285a.
  • Matzinger, P. (1994) Tolerance, danger and the extended family. Annual Review of Immunology, 12, 9911045.
  • Mayordomo, J.I., Zorina, T., Storkus, W.J., Zitvogel, L., Celluzzi, C., Falo, L.D., Melief, C.J., Ildstad, S.T., Kast, W.M., DeLeo, A.B., Lotze, M. (1995) Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Medicine, 1, 12971302.
  • Molldrem, J., Dermime, S., Parker, K., Jiang, Y.Z., Mavroudis, D., Hensel, N., Fukushima, P., Barrett, A.J. (1996) Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells. Blood, 88, 24502457.
  • Molldrem, J.J., Lee, P.P., Wang, C., Felio, K., Kantarjian, H.M., Champlin, R.E., Davis, M.M. (2000) Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nature Medicine, 6, 10181023.DOI: 10.1038/79526
  • Morse, M.A., Coleman, R.E., Akabani, G., Niehaus, N., Coleman, D., Lyerly, H.K. (1999) Migration of human dendritic cells after injection in patients with metastatic malignancies. Cancer Research, 59, 5658.
  • Mortarini, R., Di Anichini, A.N.M., Siena, S., Bregni, M., Belli, F., Molla, A., Gianni, A.M., Parmiani, G. (1997) Autologous dendritic cells derived from CD34+ progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of melan-A/Mart-1 (27–35)-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursors. Cancer Research, 57, 55345541.
  • Mutis, T., Schrama, E., Melief, C.J., Goulmy, E. (1998) CD80-Transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specific minor histocompatibility antigens and leukemia-associated antigens. Blood, 92, 16771684.
  • Mutis, T., Verdijk, R., Schrama, E., Esendam, B., Brand, A., Goulmy, E. (1999) Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens. Blood, 93, 23362341.
  • Nanda, N.K. & Sercarz, E.E. (1995) Induction of anti-self-immunity to cure cancer. Cell, 82, 1317.
  • Nestle, F.O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., Schadendorf, D. (1998) Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nature Medicine, 4, 328332.
  • Nociari, M.M., Shalev, A., Benias, P., Russo, C. (1998) A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity. Journal of Immunological Methods, 213, 157167.DOI: 10.1016/s0022-1759(98)00028-3
  • Olweus, J., BitMansour, A., Warnke, R., Thompson, P.A., Carballido, J., Picker, L.J., Lund-Johansen, F. (1997) Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proceedings of the National Academy of Sciences of the United States of America, 94, 1255112556.
  • Ostankovitch, M., Buzyn, A., Bonhomme, D., Connan, F., Bouscary, D., Heshmati, F., Dreyfus, F., Choppin, J., Guillet, J.G. (1998) Antileukemic HLA-restricted T-cell clones generated with naturally processed peptides eluted from acute myeloblastic leukemia blasts. Blood, 92, 1924.
  • Osterborg, A., Yi, Q., Henriksson, L., Fagerberg, J., Bergenbrant, S., Jeddi-Tehrani, M., Ruden, U., Lefvert, A.K., Holm, G., Mellstedt, H. (1998) Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8- and CD4-specific T-cell responses. Blood, 91, 24592466.
  • Pardoll, D.M. (1998) Cancer vaccines. Nature Medicine, 4, 525531.
  • Porgador, A. & Gilboa, E. (1995) Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. Journal of Experimental Medicine, 182, 255260.
  • Pulendran, B., Smith, J.L., Caspary, G., Brasel, K., Pettit, D., Maraskovsky, E., Maliszewski, C.R. (1999) Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proceedings of the National Academy of Sciences of the United States of America, 96, 10361041.
  • Reichardt, V.L., Okada, C.Y., Liso, A., Benike, C.J., Stockerl-Goldstein, K.E., Engleman, E.G., Blume, K.G., Levy, R. (1999) Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma – a feasibility study. Blood, 93, 24112419.
  • Reid, C.D. (1997) The dendritic cell lineage in haemopoiesis. British Journal of Haematology, 96, 217223.
  • Reid, C.D., Stackpoole, A., Meager, A., Tikerpae, J. (1992) Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. Journal of Immunology, 149, 26812688.
  • Reid, S., Penna, G., Adorini, L. (2000) The control of T cell responses by dendritic cell subsets. Current Opinion in Immunology, 12, 114121.DOI: 10.1016/s0952-7915(99)00059-x
  • Ridge, J.P., Di, R.F., Matzinger, P. (1998) A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature, 393, 474478.DOI: 10.1038/30989
  • Rissoan, M.C., Soumelis, V., Kadowaki, N., Grouard, G., De Briere, F.W.M., Liu, Y.J. (1999) Reciprocal control of T helper cell and dendritic cell differentiation. Science, 283, 11831186.DOI: 10.1126/science.283.5405.1183
  • Robertson, M.J., Cameron, C., Atkins, M.B., Gordon, M.S., Lotze, M.T., Sherman, M.L., Ritz, J. (1999) Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer. Clinical Cancer Research, 5, 916.
  • Robinson, S.P., English, N., Jaju, R., Kearney, L., Knight, S.C., Reid, C.D. (1998) The in vitro generation of dendritic cells from blast cells in acute leukaemia. British Journal of Haematology, 103, 763771.
  • Robinson, S.P., Patterson, S., English, N., Davies, D., Knight, S.C., Reid, C.D. (1999) Human peripheral blood contains two distinct lineages of dendritic cells. European Journal of Immunology, 29, 27692778.DOI: 10.1002/(sici)1521-4141(199909)29:09<2769::aid-immu2769>3.0.co;2-2
  • Romani, N., Reider, D., Heuer, M., Ebner, S., Kampgen, E., Eibl, B., Niederwieser, D., Schuler, G. (1996) Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. Journal of Immunological Methods, 196, 137151.DOI: 10.1016/0022-1759(96)00078-6
  • Romero, P., Dunbar, P.R., Valmori, D., Pittet, M., Ogg, G.S., Rimoldi, D., Chen, J.L., Lienard, D., Cerottini, J.C., Cerundolo, V. (1998) Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. Journal of Experimental Medicine, 188, 16411650.
  • Rosenberg, S.A. (1997) Cancer vaccines based on the identification of genes encoding cancer regression antigen. Immunology Today, 18, 175182.DOI: 10.1016/s0167-5699(97)84664-6
  • Roskrow, M.A., Dilloo, D., Suzuki, N., Zhong, W., Rooney, C.M., Brenner, M.K. (1999) Autoimmune disease induced by dendritic cell immunization against leukemia. Leukemia Research, 23, 549557.DOI: 10.1016/s0145-2126(99)00045-4
  • Salio, M., Cerundolo, V., Lanzavecchia, A. (2000) Dendritic cell maturation is induced by mycoplasma infection but not by necrotic cells. European Journal of Immunology, 30, 705708.DOI: 10.1002/(sici)1521-4141(200002)30:02<705::aid-immu705>3.0.co;2-c
  • Sallusto, F. & Lanzavecchia, A. (1999) Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. Journal of Experimental Medicine, 189, 611614.
  • Sallusto, F., Palermo, B., Lenig, D., Miettinen, M., Matikainen, S., Julkunen, I., Forster, R., Burgstahler, R., Lipp, M., Lanzavecchia, A. (1999) Distinct patterns and kinetics of chemokine production regulate dendritic cell function. European Journal of Immunology, 29, 16171625.DOI: 10.1002/(sici)1521-4141(199905)29:05<1617::aid-immu1617>3.0.co;2-3
  • Santiago-Schwarz, F., Belilos, E., Diamond, B., Carsons, S.E. (1992) TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. Journal of Leukocyte Biology, 52, 274281.
  • Schoenberger, S.P., Toes, R.E., Van Der Voort, E.I., Offringa, R., Melief, C.J. (1998) T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions. Nature, 393, 480483.DOI: 10.1038/31002
  • Schuler, G. & Steinman, R.M. (1997) Dendritic cells as adjuvants for immune-mediated resistance to tumors. Journal of Experimental Medicine, 186, 11831187.
  • Schultze, J., Nadler, L.M., Gribben, J.G. (1996) B7-mediated costimulation and the immune response. Blood Reviews, 10, 111127.
  • Schultze, J.L., Michalak, S., Seamon, M.J., Dranoff, G., Jung, K., Daley, J., Delgado, J.C., Gribben, J.G., Nadler, L.M. (1997) CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. Journal of Clinical Investigation, 100, 27572765.
  • Shimizu, K., Fields, R.C., Giedlin, M., Mule, J.J. (1999) Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines. Proceedings of the National Academy of Sciences of the United States of America, 96, 22682273.
  • Shlomchik, W.D., Couzens, M.S., Tang, C.B., McNiff, J., Robert, M.E., Liu, J., Shlomchik, M.J., Emerson, S.G. (1999) Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science, 285, 412415.DOI: 10.1126/science.285.5426.412
  • Siegal, F.P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P.A., Shah, K., Ho, S., Antonenko, S., Liu, Y.J. (1999) The nature of the principal type 1 interferon-producing cells in human blood. Science, 284, 18351837.DOI: 10.1126/science.284.5421.1835
  • Slavin, S., Nagler, A., Naparstek, E., Kapelushnik, Y., Aker, M., Cividalli, G., Viradi, G., Kirschbaum, M., Ackerstein, A., Samuel, S., Amar, A., Brautbar, C., Ben-Tal, O., Eldor, A., Or, R. (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant haematologic diseases. Blood, 91, 756763.
  • Smit, W.M., Rijnbeek, M., Van Bergen, C.A., Fibbe, W.E., Willemze, R., Falkenburg, J.H. (1998) T cells recognizing leukemic CD34 (+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation. Proceedings of the National Academy of Sciences of the United States of America, 95, 1015210157.
  • Soiffer, R., Lynch, T., Mihm, M., Jung, K., Rhuda, C., Schmollinger, J.C., Hodi, F.S., Liebster, L., Lam, P., Mentzer, S., Singer, S., Tanabe, K.K., Cosimi, A.B., Duda, R., Sober, A., Bhan, A., Daley, J., Neuberg, D., Parry, G., Rokovich, J., Richards, L., Drayer, J., Berns, A., Clift, S., Dranoff, G., Cohen, L., Mulligan, R. (1998) Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. Proceedings of the National Academy of Sciences of the United States of America, 95, 1314113146.
  • Specht, J.M., Wang, G., Do, M.T., Lam, J.S., Royal, R.E., Reeves, M.E., Rosenberg, S.A., Hwu, P. (1997) Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases. Journal of Experimental Medicine, 186, 12131221.
  • Steinbrink, K., Jonuleit, H., Muller, G., Schuler, G., Knop, J., Enk, A. (1999) Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8+ T cells resulting in a failure to lyse tumor cells. Blood, 93, 16341642.
  • Steinman, R.M., Pack, M., Inaba, K. (1997) Dendritic cells in the T-cell areas of lymphoid organs. Immunological Reviews, 156, 2537.
  • Suss, G. & Shortman, K. (1996) A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. Journal of Experimental Medicine, 183, 17891796.
  • Suto, R. & Srivastava, P. (1995) A mechanism for the specific immunogeneicity of heat shock protein-chaperoned peptides. Science, 269, 15851588.
  • Tarte, K., Zhang, X.G., Legouffe, E., Hertog, C., Mehtali, M., Rossi, J.F. & Klein, B. (1999) Induced expression of B7–1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells. Journal of Immunology, 163, 514524.
  • Titzer, S., Christensen, O., Manzke, O., Tesch, H., Wolf, J., Emmerich, B., Carsten, C., Diehl, V., Bohlen, H. (2000) Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects. British Journal of Haematology, 108, 805816.DOI: 10.1046/j.1365-2141.2000.01958.x
  • Toes, R.E., Van, D.V.I., Schoenberger, S.P., Drijfhout, J.W., Van, B.L., Storm, G., Kast, W.M., Offringa, R., Melief, C.J. (1998) Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells. Journal of Immunology, 160, 44494456.
  • Toes, R.E., Ossendorp, F., Offringa, R., Melief, C.J. (1999) CD4 T cells and their role in antitumor immune responses. Journal of Experimental Medicine, 189, 753756.
  • Van Baren, N., Brasseur, F., Godelaine, D., Hames, G., Ferrant, A., Lehmann, F., Andre, M., Ravoet, C., Doyen, C., Spagnoli, G.C., Bakkus, M., Thielemans, K., Boon, T. (1999) Genes encoding tumor-specific antigens are expressed in human myeloma cells. Blood, 94, 11561164.
  • Wu, T.C., Huang, A.Y., Jaffee, E.M., Levitsky, H.I., Pardoll, D.M. (1995) A reassessment of the role of B7–1 expression in tumor rejection. Journal of Experimental Medicine, 182, 14151421.
  • Yanuck, M., Carbone, D., Pendleton, C., Tsukui, T., Winter, S., Minna, J., Berzofsky, J. (1993) A mutant p53 tumour suppressor protein is a target for peptide-induced CD8+ cytotoxic T cells. Cancer Research, 53, 32573261.
  • Young, J.W. (1999) Dendritic cells: expansion and differentiation with hematopoietic growth factors. Current Opinion in Hematology, 6, 135144.
  • Young, J.W. & Inaba, K. (1996) Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. Journal of Experimental Medicine, 183, 711.
  • Zajac, A., Blattman, J., Murali-Krishna, K., Sourdive, D., Suresh, M., Altman, J., Ahmed, R. (1998) Viral immune evasion due to persistence of activated T cells without effector function. Journal of Experimental Medicine, 188, 22052213.
  • Zitvogel, L., Mayordomo, J.I., Tjandrawan, T., DeLeo, A.B., Clarke, M.R., Lotze, M.T., Storkus, W.J. (1996) Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. Journal of Experimental Medicine, 183, 8797.